It could be as simple as: eating less, losing weight, and giving up foods you love is hard
Take the first steps toward a new you today
The results of the phase 3a PIONEER TEENS study will underpin filings of the drug under the Ozempic and Rybelsus brand names before the end of 2026, and according to Novo Nordisk could become the first oral GLP-1 therapies approved for use in paediatric T2D patients
This research was supported by National Institute on Alcohol Abuse and Alcoholism grant R21AA026931.
Participants typically lost weight continuously for 65 weeks before reaching a plateau
Weina H, Yuhu N, Christian H, Birong L, Feiyu S, Le W (2018) Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity